Literature DB >> 4972295

Alpha-2-macroglobulin levels in disease in man.

J Housley.   

Abstract

Serum alpha(2)-macroglobulin levels were measured in normal subjects and in patients with various diseases by an immunochemical method. The values for normal men were 284 mg./100 ml. (+/-89.6 mg./100 ml.) and for normal women 350 mg./100 ml. (+/-94.5 mg./100 ml.). Men with rheumatoid arthritis had normal levels, but the levels in women were depressed. There was no relationship to the concentrations of the acute phase reactive proteins, haptoglobin, and C-reactive protein. In chronic liver disease, the levels in men were significantly higher than normal and were slightly higher than normal in women.A small group of patients with nephrotic syndrome had very high levels. No significant variations from the normal were found in sera from a group of patients with miscellaneous diseases.

Entities:  

Mesh:

Substances:

Year:  1968        PMID: 4972295      PMCID: PMC473657          DOI: 10.1136/jcp.21.1.27

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  16 in total

1.  PREPARATION OF ANTISERA SPECIFIC FOR 6.6 S GAMMA-GLOBULINS, BETA 2A-GLOBULINS, GAMMA-1.-MACROGLOBULINS, AND FOR TYPE I AND II COMMON GAMMA-GLOBULIN DETERMINANTS.

Authors:  J L FAHEY; C MCLAUGHLIN
Journal:  J Immunol       Date:  1963-10       Impact factor: 5.422

2.  A gel diffusion precipitin method for the estimation of C-reactive protein.

Authors:  R A CROCKSON
Journal:  J Clin Pathol       Date:  1963-05       Impact factor: 3.411

3.  [On changes in the alpha 2 globulins of the serum].

Authors:  G SCHUMACHER; H D SCHLUMBERGER
Journal:  Dtsch Med Wochenschr       Date:  1963-03-29       Impact factor: 0.628

4.  Protein binding of pancreatic proteolytic enzymes.

Authors:  B J HAVERBACK; B DYCE; H F BUNDY; S K WIRTSCHAFTER; H A EDMONDSON
Journal:  J Clin Invest       Date:  1962-05       Impact factor: 14.808

5.  [On the quantitative determination of specific protein fractions. Methodical studies with special reference to immunochemical methods. I].

Authors:  W H HITZIG
Journal:  Int Arch Allergy Appl Immunol       Date:  1961

6.  [Quantitative immunological determination of blood proteins].

Authors:  H E SCHULTZE; G SCHWICK
Journal:  Clin Chim Acta       Date:  1959-01       Impact factor: 3.786

7.  The metabolism of estrogens by the human liver studied in vitro.

Authors:  H J TAGNON; S LIEBERMAN; P SCHULMAN; A BRUNSCHWIG
Journal:  J Clin Invest       Date:  1952-04       Impact factor: 14.808

8.  Dissociation of esterolytic and clotting activities of thrombin by trypsin-binding macroglobulin.

Authors:  G F Lanchantin; M L Plesset; J A Friedmann; D W Hart
Journal:  Proc Soc Exp Biol Med       Date:  1966-02

9.  Time sequence of acute phase reactive proteins following surgical trauma.

Authors:  R A Crockson; C J Payne; A P Ratcliff; J F Soothill
Journal:  Clin Chim Acta       Date:  1966-10       Impact factor: 3.786

10.  [Role of alpha-2-macroglobulin of human serum in the fixation in vitro of iodine-131 labeled bovine insulin].

Authors:  G R Zahnd; J J Scheidegger
Journal:  Helv Med Acta       Date:  1963-11
View more
  11 in total

1.  The alpha2-macroglobulin level in cerebrospinal fluid; a parameter for the condition of the blood-CSF barrier.

Authors:  G Schliep; K Felgenhauer
Journal:  J Neurol       Date:  1974       Impact factor: 4.849

2.  Long-term effects of carbon tetrachloride and sodium phenobarbitone administration on rat serum proteins.

Authors:  C H Horne; W D Thompson; A Busuttil; R N MacSween
Journal:  Br J Exp Pathol       Date:  1973-04

3.  [Endogenous inhibitors of fibrinolytic activity in liver cirrhosis (author's transl)].

Authors:  R Aschauer; F Holzknecht; S Platzer
Journal:  Klin Wochenschr       Date:  1973-12-01

4.  Serum -macroglobulins in renal disease and preeclampsia.

Authors:  C H Horne; J D Briggs; P W Howie; A C Kennedy
Journal:  J Clin Pathol       Date:  1972-07       Impact factor: 3.411

5.  Acute phase proteins are major clients for the chaperone action of α₂-macroglobulin in human plasma.

Authors:  Amy R Wyatt; Nathan W Zammit; Mark R Wilson
Journal:  Cell Stress Chaperones       Date:  2012-08-16       Impact factor: 3.667

Review 6.  Nanoparticle personalized biomolecular corona: implications of pre-existing conditions for immunomodulation and cancer.

Authors:  Jacob Shaw; Ryan M Pearson
Journal:  Biomater Sci       Date:  2022-05-17       Impact factor: 7.590

7.  Abnormal glycosylation of alpha 2-macroglobulin, a non-acute-phase protein in patients with autoimmune diseases.

Authors:  L Saso; B Silvestrini; A Guglielmotti; R Lahita; C Y Cheng
Journal:  Inflammation       Date:  1993-08       Impact factor: 4.092

8.  Normal and pathological serum levels of alpha2-macroglobulins in men and mice.

Authors:  A M Tunstall; J M Merriman; I Milne; K James
Journal:  J Clin Pathol       Date:  1975-02       Impact factor: 3.411

9.  Plasma levels of alpha1-antichymotrypsin and secretory leukocyte proteinase inhibitor in healthy and chronic obstructive pulmonary disease (COPD) subjects with and without severe alpha1-antitrypsin deficiency.

Authors:  Camilla Hollander; Ulla Westin; Anders Wallmark; Eeva Piitulainen; Tomas Sveger; Sabina M Janciauskiene
Journal:  BMC Pulm Med       Date:  2007-01-29       Impact factor: 3.317

10.  Identification of serum glycoprotein ligands for the immunomodulatory receptor blood dendritic cell antigen 2.

Authors:  Jong-Won Kim; James Budzak; Yu Liu; Sabine A F Jégouzo; Kurt Drickamer; Maureen E Taylor
Journal:  Glycobiology       Date:  2018-08-01       Impact factor: 4.313

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.